As on Thursday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) started slowly as it slid -0.43% to $4.59, before settling in for the price of $4.61 at the close. Taking a more long-term approach, IRWD posted a 52-week range of $3.06-$15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 5.56%. Meanwhile, its Annual Earning per share during the time was -28.37%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 101.55%. This publicly-traded company’s shares outstanding now amounts to $160.02 million, simultaneously with a float of $155.77 million. The organization now has a market capitalization sitting at $734.53 million. At the time of writing, stock’s 50-day Moving Average stood at $4.00, while the 200-day Moving Average is $5.70.
Ironwood Pharmaceuticals Inc (IRWD) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Ironwood Pharmaceuticals Inc’s current insider ownership accounts for 2.66%, in contrast to 103.18% institutional ownership. According to the most recent insider trade that took place on Nov 18 ’24, this organization’s SVP, Chief Business Officer sold 5,360 shares at the rate of 4.08, making the entire transaction reach 21,869 in total value, affecting insider ownership by 284,685. Preceding that transaction, on Nov 18 ’24, Company’s SVP, COO and CFO sold 11,001 for 4.08, making the whole transaction’s value amount to 44,884. This particular insider is now the holder of 309,572 in total.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Revenue Records
Ironwood Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 101.55% and is forecasted to reach 0.25 in the upcoming year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Let’s observe the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). It’s Quick Ratio in the last reported quarter now stands at 3.62. The Stock has managed to achieve an average true range (ATR) of 0.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.94. Similarly, its price to free cash flow for trailing twelve months is now 5.93.
In the same vein, IRWD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.02, a figure that is expected to reach 0.06 in the next quarter, and analysts are predicting that it will be 0.25 at the market close of one year from today.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Through scrutinizing the latest numbers posted by the [Ironwood Pharmaceuticals Inc, IRWD], it can be observed that its last 5-days Average volume of 3.75 million was better the volume of 2.85 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 70.14% While, its Average True Range was 0.39.
Raw Stochastic average of Ironwood Pharmaceuticals Inc (IRWD) in the period of the previous 100 days is set at 47.52%, which indicates a major fall in contrast to 73.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 99.32% that was higher than 97.87% volatility it exhibited in the past 100-days period.
